Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Investing

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Jul 24, 2016 at 10:50 AM EDT

Top Dow Earnings for the Week Ahead

Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jul 6, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA Wednesday

July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Paul Ausick | Jun 29, 2016 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow Wednesday

June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Paul Ausick | Jun 17, 2016 at 4:01 PM EDT

The 4 Stocks That Tanked the Dow on Friday

June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed…

Paul Ausick | Jun 16, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Thursday

June 16, 2016: Markets opened lower Thursday but equities showed some spunk by trading on an upward trend for nearly…

Chris Lange | Jun 10, 2016 at 11:05 AM EDT

Merck Moves to Acquire Afferent Pharma

Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.

Chris Lange | Jun 10, 2016 at 8:05 AM EDT

Major Pharma Has Short Sellers on the Run

The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

Chris Lange | Jun 2, 2016 at 10:50 AM EDT

Merrill Lynch Picks ASCO Winners

Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…

Paul Ausick | May 25, 2016 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Wednesday

May 25, 2016: Markets opened higher again Wednesday on news that eurozone ministers have agreed to release the next tranche…

Chris Lange | May 25, 2016 at 8:15 AM EDT

Short Sellers Take Mixed Stance on Major Pharma

The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | May 11, 2016 at 8:45 AM EDT

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical…

1 … 35 36 37 38 39 … 72

Merck : MRK

All Merck Articles

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Lifted the Dow on Thursday

Merck Moves to Acquire Afferent Pharma

Major Pharma Has Short Sellers on the Run

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

The 4 Stocks That Boosted the DJIA on Wednesday

Short Sellers Take Mixed Stance on Major Pharma

Major Pharma Short Interest Continues to Recede

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

Merck : MRK

All Merck Articles

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Lifted the Dow on Thursday

Merck Moves to Acquire Afferent Pharma

Major Pharma Has Short Sellers on the Run

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

The 4 Stocks That Boosted the DJIA on Wednesday

Short Sellers Take Mixed Stance on Major Pharma

Major Pharma Short Interest Continues to Recede

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

Investors Are Ditching the Magnificent 7 For a New Group of Stocks: The MANGOS

1 Plain-As-Day Dividend King to Buy and Never Sell That Has Paid a Continuous Dividend Since 1891

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

Featured Reads

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge